Stephen C. Mathai

Stephen C. Mathai

Pulmonary Medicine

601 North Caroline Street, Floor 7
Floor 7
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 213 publications

Ralinepag in pulmonary arterial hypertension: a step forward.

Ralinepag in pulmonary arterial hypertension: a step forward.

Journal: Lancet (London, England)

Published: July 28, 2026

Metabolomic Network Analysis Reveals Reorganization of Lipid and Steroid Programs Linked to Right Ventricular-Pulmonary Vascular Function in Pulmonary Hypertension.

Metabolomic Network Analysis Reveals Reorganization of Lipid and Steroid Programs Linked to Right Ventricular-Pulmonary Vascular Function in Pulmonary Hypertension.

Journal: bioRxiv : the preprint server for biology

Published: July 03, 2026

Resolving Diagnostic Discordance in Group 2 Pulmonary Hypertension Through Staged Physiologic Testing: Insights From PVDOMICS.

Resolving Diagnostic Discordance in Group 2 Pulmonary Hypertension Through Staged Physiologic Testing: Insights From PVDOMICS.

Journal: medRxiv : the preprint server for health sciences

Published: June 22, 2026

Metabolomics of Right Ventricular Function in Pulmonary Hypertension.

Metabolomics of Right Ventricular Function in Pulmonary Hypertension.

Journal: Circulation research

Published: April 15, 2026

Metabolomics of Right Ventricular Function in Pulmonary Hypertension.

Metabolomics of Right Ventricular Function in Pulmonary Hypertension.

Journal: Circulation research

Published: April 15, 2026

Increased Xanthine Oxidoreductase Activity in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.

Increased Xanthine Oxidoreductase Activity in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.

Journal: CHEST pulmonary

Published: April 02, 2026

Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension.

Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension.

Journal: Circulation

Published: February 13, 2026

National Patterns of Pulmonary Hypertension Mortality in the United States, 2010 to 2024.

National Patterns of Pulmonary Hypertension Mortality in the United States, 2010 to 2024.

Journal: The American journal of cardiology

Published: December 15, 2025

Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary Hypertension.

Prevalence and Clinical Implications of Excess Adiposity in Group 1 Pulmonary Hypertension.

Journal: Circulation. Heart failure

Published: December 03, 2025

Risk averse: assessing risk as a surrogate measure in pulmonary arterial hypertension.

Risk averse: assessing risk as a surrogate measure in pulmonary arterial hypertension.

Journal: American journal of respiratory and critical care medicine

Published: November 18, 2025

The Minimal Important Difference in N-Terminal Pro-Brain Natriuretic Peptide in Pulmonary Hypertension.

The Minimal Important Difference in N-Terminal Pro-Brain Natriuretic Peptide in Pulmonary Hypertension.

Journal: Chest

Published: November 11, 2025

Blood Pressure Change After Six-minute Walk Test Is an Independent Predictor of Clinical Worsening in Patients with Pulmonary Hypertension.

Blood Pressure Change After Six-minute Walk Test Is an Independent Predictor of Clinical Worsening in Patients with Pulmonary Hypertension.

Journal: Annals of the American Thoracic Society

Published: October 01, 2025

Showing 1-12 of 213

Last Updated: 09/26/2026